DECA DURABOLIN

This brand name is authorized in Austria, Brazil, Ecuador, Estonia, Finland, Hong Kong SAR China, Malta, Mexico, Netherlands, Poland, Singapore, UK.

Active ingredients

The drug DECA DURABOLIN contains one active pharmaceutical ingredient (API):

1	Nandrolone UNII H45187T098 - NANDROLONE DECANOATE
	Nandrolone is chemically related to testosterone and shows enhanced anabolic and a reduced androgenic activity. In humans nandrolone has been shown to positively influence calcium metabolism and to increase bone mass in osteoporosis.
	Read more about Nandrolone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DECA-DURABOLIN Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A14AB01	Nandrolone	A Alimentary tract and metabolism → A14 Anabolic agents for systemic use → A14A Anabolic steroids → A14AB Estren derivatives
Discover more medicines within A14AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	505618090044117, 505618090044217
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	3221-MEE-0418
EE	Ravimiamet	1534238, 1888353
FI	Lääkealan turvallisuus- ja kehittämiskeskus	189969
GB	Medicines & Healthcare Products Regulatory Agency	38803
HK	Department of Health Drug Office	06876
MT	Medicines Authority	AA565/35702
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	53979
NL	Z-Index G-Standaard	12113409
NL	Z-Index G-Standaard, PRK	4774
PL	Rejestru Produktów Leczniczych	100015932, 100257983, 100333098, 100397879, 100399335, 100412159, 100420897, 100446224
SG	Health Sciences Authority	04300P